Advanced search
Publication Cover
Journal of Drug Targeting Volume 17, 2009 - Issue 2
Submit an article Journal homepage
105
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Inhibitory effect of small interfering RNA specific for a novel candidate target in PB1 gene of influenza A virus

Congsheng Cheng
,
Lihong Yao State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100 Yingxin Jie, Xuanwu District, 100052 Beijing, P.R. China
,
Aijun Chen State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100 Yingxin Jie, Xuanwu District, 100052 Beijing, P.R. China
,
Runqing Jia State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100 Yingxin Jie, Xuanwu District, 100052 Beijing, P.R. China
,
Lifang Huan State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100 Yingxin Jie, Xuanwu District, 100052 Beijing, P.R. China
,
Jianqiang Guo State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100 Yingxin Jie, Xuanwu District, 100052 Beijing, P.R. China
,
Hong Bo State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100 Yingxin Jie, Xuanwu District, 100052 Beijing, P.R. China
,
Yuelong Shu State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100 Yingxin Jie, Xuanwu District, 100052 Beijing, P.R. ChinaCorrespondence[email protected]
&
Zhiqing Zhang State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100 Yingxin Jie, Xuanwu District, 100052 Beijing, P.R. ChinaCorrespondence[email protected]
 show all
Pages 133-139 | Received 28 May 2008, Accepted 11 Sep 2008, Published online: 20 Jan 2009

References

  • JR Bennink, and TN Palmore. (2004). The promise of siRNAs for the treatment of influenza. Trends Mol Med 10 (12):571–574.
  • A Birmingham, E Anderson, K Sullivan, A Reynolds, Q Boese, D Leake, J Karpilow, and A Khvorova. (2007). A protocol for designing siRNAs with high functionality and specificity. Nat Protoc 2 (9):2068–2078.
  • AN Chanturiya, G Basanez, U Schubert, P Henklein, JW Yewdell, and J Zimmerberg. (2004). PB1-F2, an Influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J Virol 78 (12):6304–6312.
  • W Chen, PA Calvo, D Malide, J Gibbs, U Schubert, I Bacik, S Basta, R O'Neill, J Schickli, P Palese, P Henklein, JR Bennink, and JW Yewdell. (2001). A novel Influenza A virus mitochondrial protein that induces cell death. Nat Med 7 (12):1306–1312.
  • C Cheng, J Dong, L Yao, A Chen, R Jia, L Huan, J Guo, Y Shu, and Z Zhang. (2008). Potent inhibition of human Influenza H5N1 virus by oligonucleotides derived by SELEX. Biochem Biophys Res Commun 366 (3):670–674.
  • JR Coleman. (2007). The PB1-F2 protein of Influenza A virus: Increasing pathogenicity by disrupting alveolar macrophages. Virol J 4:9.
  • E De Clercq. (2006). Antiviral agents active against Influenza A viruses. Nat Rev Drug Discov 5 (12):1015–1025.
  • SM Elbashir, J Harborth, W Lendeckel, A Yalcin, K Weber, and T Tuschl. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (6836):494–498.
  • DS Fedson. (2003). Pandemic influenza and the global vaccine supply. Clin Infect Dis 36 (12):1552–1561.
  • Q Ge, MT McManus, T Nguyen, CH Shen, PA Sharp, HN Eisen, and J Chen. (2003). RNA interference of Influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci USA 100 (5):2718–2723.
  • Q Ge, HN Eisen, and J Chen. (2004). Use of siRNAs to prevent and treat Influenza virus infection. Virus Res 102 (1):37–42.
  • LV Gubareva, JA McCullers, RC Bethell, and RG Webster. (1998). Characterization of Influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of Zanamivir on H5N1 infection in mice. J Infect Dis 178 (6):1592–1596.
  • I Mazur, D Anhlan, D Mitzner, L Wixler, U Schubert, and S Ludwig. (2008). The proapoptotic Influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol 10 (5):1140–1152.
  • JL McAuley, F Hornung, KL Boyd, AM Smith, R McKeon, J Bennink, JW Yewdell, and JA McCullers. (2007). Expression of the 1918 Influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2 (4):240–249.
  • JK Taubenberger, and DM Morens. (2007). The pathology of Influenza virus infections. Annu Rev Pathol 3:499–522.
  • E Turpin, K Luke, J Jones, T Tumpey, K Konan, and S Schultz-Cherry. (2005). Influenza virus infection increases p53 activity: Role of p53 in cell death and viral replication. J Virol 79 (14):8802–8811.
  • I Vermes, C Haanen, H Steffens-Nakken, and C Reutelingsperger. (1995). A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184 (1):39–51.
  • D Zamarin, MB Ortigoza, and P Palese. (2006). Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80 (16):7976–7983.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.